Scinovex
review Open AccessTop 1% cited

The COVID-19 Cytokine Storm; What We Know So Far

Frontiers in Immunology · 2020 · Vol. 11 · pp. 1446–1446
Dina RagabHaitham Salah EldinMohamed TaeimahRasha KhattabRamy Salem

Abstract

COVID-19 is a rapidly spreading global threat that has been declared as a pandemic by the WHO. COVID-19 is transmitted via droplets or direct contact and infects the respiratory tract resulting in pneumonia in most of the cases and acute respiratory distress syndrome (ARDS) in about 15 % of the cases. Mortality in COVID-19 patients has been linked to the presence of the so-called "cytokine storm" induced by the virus. Excessive production of proinflammatory cytokines leads to ARDS aggravation and widespread tissue damage resulting in multi-organ failure and death. Targeting cytokines during the management of COVID-19 patients could improve survival rates and reduce mortality.

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and healthcare impactsARDSCytokine stormProinflammatory cytokineCoronavirus disease 2019 (COVID-19)PneumoniaMedicinePandemicIntensive care medicineCytokineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

MeSH terms

BetacoronavirusCytokine Release SyndromeCOVID-19SARS-CoV-2Interleukin-6 InhibitorsCOVID-19 Drug TreatmentHumansPneumonia, ViralRespiratory Distress SyndromeInterleukin-6CytokinesCoronavirus InfectionsReceptors, Interleukin-6PandemicsAntibodies, Monoclonal, Humanized
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.